Tc-99m-labeled fibrinogen receptor antagonists: design and synthesis of cyclic RGD peptides for the detection of thrombi
- 6 August 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (15), 1741-1746
- https://doi.org/10.1016/0960-894x(96)00282-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Labeling Cyclic Glycoprotein IIb/IIIa Receptor Antagonists with 99mTc by the Preformed Chelate Approach: Effects of Chelators on Properties of [99mTc]Chelator−Peptide ConjugatesBioconjugate Chemistry, 1996
- Thrombus Imaging Using Technetium-99m-Labeled High-Potency GPIIb/IIIa Receptor Antagonists. Chemistry and Initial Biological StudiesJournal of Medicinal Chemistry, 1996
- Synthesis and antiplatelet activity of DMP 757 analogsBioorganic & Medicinal Chemistry Letters, 1995
- Prevalence of deep venous thrombosis among patients in medical intensive careJAMA, 1995
- Antithrombotic agents: From RGD to peptide mimeticsBioorganic & Medicinal Chemistry, 1995
- Technetium Radiopharmaceuticals—Fundamentals, Synthesis, Structure, and DevelopmentAngewandte Chemie International Edition in English, 1994
- Nuclear Medicine and Positron Emission Tomography: An OverviewJournal of Chemical Education, 1994
- Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIaJournal of the American Chemical Society, 1994
- Preparation and structural characterization of monoamine-monoamide bis(thiol) oxo complexes of technetium(V) and rhenium(V)Inorganic Chemistry, 1994
- Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological propertiesJournal of the American Chemical Society, 1990